Effect of basiliximab on renal allograft rejection within 1 year after transplantation.

[1]  F. McArdle,et al.  Calcineurin Inhibitors and Proximal Renal Tubular Injury in Renal Transplant Patients with Proteinuria and Chronic Allograft Nephropathy , 2005, Transplantation.

[2]  P. Lertsithichai,et al.  The role of anti-IL-2 receptor in high-risk kidney transplant patients. , 2004, Transplantation proceedings.

[3]  C. Ponticelli,et al.  From cyclosporine to the future. , 2004, Transplantation proceedings.

[4]  S. Nehlsen-Cannarella,et al.  Use of basiliximab with mycophenolate mofetil in kidney transplantation. , 2003, Transplantation proceedings.

[5]  S. Yousaf,et al.  Safety and efficacy of basiliximab for the prevention of acute rejection in kidney transplant recipients. , 2003, Transplantation proceedings.

[6]  A. Mendiluce,et al.  Tacrolimus-Basiliximab versus Cyclosporine-Basiliximab in renal transplantation "de novo": acute rejection and complications. , 2003, Transplantation proceedings.

[7]  F. Oppenheimer,et al.  Immunoprophylaxis with Simulect (basiliximab) in kidney transplantation: results from routine clinical practice at 18 kidney transplant units. , 2003, Transplantation proceedings.

[8]  B. Maes,et al.  The use of an anti‐CD25 monoclonal antibody and mycophenolate mofetil enables the use of a low‐dose tacrolimus and early withdrawal of steroids in renal transplant recipients , 2003, Clinical transplantation.

[9]  A. Yussim,et al.  Rejection rate in living donor kidney transplantation with and without basiliximab in tacrolimus/mycophenolate mofetil-based protocol. , 2003, Transplantation proceedings.

[10]  Y. Yamaguchi,et al.  Immunohistochemical analysis of tubulointerstitial changes of chronic allograft nephropathy. , 2003, Transplantation Proceedings.

[11]  J. Roberts,et al.  A calcineurin inhibitor‐sparing regimen with sirolimus, mycophenolate mofetil, and anti‐CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function , 2000, Clinical transplantation.

[12]  Y. Vanrenterghem.  Strategies to reduce or replace steroid dosing. , 1999, Transplantation proceedings.

[13]  D. Dunn,et al.  Risk factors for chronic rejection in renal allograft recipients. , 1993, Transplantation.